drugset / Trial / NCT06465641
Methylphenidate in KBG Syndrome: N-of-1 Series
RandomizedCrossoverQuadruple-blindTreatment
Summary
The goal of this clinical trial\] is to learn about the effect of methylphenidate in children and adolescents with KBG syndrome. The main question it aims to answer is: • What is the effectiveness of methylphenidate on attention deficit and ADHD-related symptoms in children and adolescents with KBG syndrome? Participants will receive multiple blocks of treatment with methylphenidate and placebo and fill out various questionnaires.
Timeline
- Start
- 2024-11-13
- Primary completion
- 2027-01-01
- Completion
- 2027-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | — | — |